Navigation par Sujet
Montrant les résultats 1 à 20 de 4566
suivant >
- a conception et la réalisation 1
- a emaintenance industrielle 1
- A few cases of thrombocytopenia and APS-like thrombotic events have been reported in recipients of adenoviral vector-based COVID-19 vaccines. However, the association of aPL with COVID-19 vaccination is unclear. In our study, the comparison between the 03 groups: COVID-19 patients (n=106), vaccine receivers (n=38) and healthy controls (n=70), showed aPL rates at : 40%, 84 % and 19% respectively. We found highly significant values of aPL levels: in COVID-19 patients vs healthy controls (p=0.005/OR=2.88), vaccine receivers vs healthy controls (p=10-10 /OR=18.63), vaccine receivers vs COVID-19 patients (p=10-5/OR=6.48). COVID-19 patients showed statistically significant values in anti-B2GP1 IgM positivity compared to vaccine receivers and healthy controls (p=0.004, p=0.015 respectively). While vaccine receivers showed very highly statistically significant values in aCL IgM positivity compared to COVID-19 patients and healthy controls (p=10-9, p=10-12 respectively). These considerations suggest that aPL may represent a risk factor for thrombotic events after COVID-19 vaccination and warrant further investigations. 1
- a langue arabe 1
- A*. 1
- a-Al2O3 1
- A-angiokeratome 1
- A-CDM; ATFM;# CDM; Collaboration ATFM/CDM 1
- a-IGZO, Transistor à couche couches mince (TFT), Simulation (SILVACO /ATLAS) 1
- a-IGZO, Transistor à couches minces, Simulation, SILVACO, TFT 1
- a-pinene, bioconversion 1
- a-pinène 1
- A. aurantii, 1
- A. baumannii MDR 1
- A. baumannii XDR 1
- A. citricola 1
- A. herba alba 2
- A. pomi 1
- A. semibacatta 1
- A. Tumefaciens 1